Gabapentin in the treatment of opioid dependency
Phase 2
- Conditions
- opium withdrawal.Mental and behavioural disorders due to use of opioids
- Registration Number
- IRCT138805102266N1
- Lead Sponsor
- Vice Chancellor for Research of Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 31
Inclusion Criteria
opioid dependency ( based on DSM-IV-TR) for at least one year, stable dose of opium for at least one month prior to the study. Exclusion criteria: having a history of illicit drugs use other than opium, psychiatric medication and other substances use except cigarettes for a period of two months prior to the study, major psychiatric disorder, severe concurrent medical illness, organic brain disorder, mental retardation, pregnancy and lactation
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of total opium withdrawal symptoms severity. Timepoint: 0(base line)and days of 3,7,10,14,18 after initiation of study. Method of measurement: Subjective Opiate Withdrawal Scale (SOWS).
- Secondary Outcome Measures
Name Time Method Evaluation of different withdrawal symptoms severity. Timepoint: 0(base line)and days of 3,7,10,14,18 after initiation of study. Method of measurement: Subjective Opiate Withdrawal Scale (SOWS),.